Supplier
Supplier
SUN PHARMA UK LIMITED
Location unknown
Nationwide NHS framework for supplying generic pharmaceutical products across multiple regions in three product categories, commencing February 2027 with terms ranging from 8 to 40 months.
Procurement for medicinal products including generics, branded generics, and proprietary pharmaceuticals under Group 18 classification.
NHS is seeking suppliers for a national two-year framework agreement to provide Lenalidomide, Pomalidomide, and Thalidomide across all English regions, with potential extensions up to 48 months.